Industry Research Reports

Home > Reports > Pharma & Healthcare > Alzheimer's Treatment Drug - Global Market Insights and Sales Trends 2024

Alzheimer's Treatment Drug - Global Market Insights and Sales Trends 2024

Industry: Pharma & Healthcare

Published: 2023-12-08

Pages: 93 Pages

Report ld: 1946396

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Alzheimer's Treatment Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Treatment Drug in various end use industries. The expanding demands from the Early to Moderate Stages and Moderate to Severe Stages, are propelling Alzheimer's Treatment Drug market. Donepezil, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Memantine segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alzheimer's Treatment Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Alzheimer's Treatment Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Alzheimer's Treatment Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alzheimer's Treatment Drug sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Alzheimer's Treatment Drug covered in this report include AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson and Lundbeck, etc.

The global Alzheimer's Treatment Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Report Metric
Details
Report Title
Alzheimer's Treatment Drug - Global Market Insights and Sales Trends 2024
Global Alzheimer's Treatment Drug Companies Covered
AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson, Lundbeck
Global Alzheimer's Treatment Drug Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alzheimer's Treatment Drug Market, Segment by Type
Donepezil

Memantine

Rivastigmine
Global Alzheimer's Treatment Drug Market, Segment by Application
Early to Moderate Stages

Moderate to Severe Stages
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alzheimer's Treatment Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alzheimer's Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

 1 Alzheimer's Treatment Drug Market Overview
    1.1 Alzheimer's Treatment Drug Product Overview
    1.2 Alzheimer's Treatment Drug Market Segment by Type
        1.2.1 Donepezil
        1.2.2 Memantine
        1.2.3 Rivastigmine
    1.3 Global Alzheimer's Treatment Drug Market Size by Type
        1.3.1 Global Alzheimer's Treatment Drug Market Size Overview by Type (2018-2029)
        1.3.2 Global Alzheimer's Treatment Drug Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Alzheimer's Treatment Drug Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Alzheimer's Treatment Drug Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Alzheimer's Treatment Drug Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Alzheimer's Treatment Drug Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Alzheimer's Treatment Drug Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Alzheimer's Treatment Drug Sales Breakdown by Type (2018-2023)

 2 Global Alzheimer's Treatment Drug Market Competition by Company
    2.1 Global Top Players by Alzheimer's Treatment Drug Sales (2018-2023)
    2.2 Global Top Players by Alzheimer's Treatment Drug Revenue (2018-2023)
    2.3 Global Top Players by Alzheimer's Treatment Drug Price (2018-2023)
    2.4 Global Top Manufacturers Alzheimer's Treatment Drug Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Alzheimer's Treatment Drug Market Competitive Situation and Trends
        2.5.1 Alzheimer's Treatment Drug Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Alzheimer's Treatment Drug Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drug as of 2022)
    2.7 Date of Key Manufacturers Enter into Alzheimer's Treatment Drug Market
    2.8 Key Manufacturers Alzheimer's Treatment Drug Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Alzheimer's Treatment Drug Status and Outlook by Region
    3.1 Global Alzheimer's Treatment Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Alzheimer's Treatment Drug Historic Market Size by Region
        3.2.1 Global Alzheimer's Treatment Drug Sales in Volume by Region (2018-2023)
        3.2.2 Global Alzheimer's Treatment Drug Sales in Value by Region (2018-2023)
        3.2.3 Global Alzheimer's Treatment Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Alzheimer's Treatment Drug Forecasted Market Size by Region
        3.3.1 Global Alzheimer's Treatment Drug Sales in Volume by Region (2024-2029)
        3.3.2 Global Alzheimer's Treatment Drug Sales in Value by Region (2024-2029)
        3.3.3 Global Alzheimer's Treatment Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Alzheimer's Treatment Drug by Application
    4.1 Alzheimer's Treatment Drug Market Segment by Application
        4.1.1 Early to Moderate Stages
        4.1.2 Moderate to Severe Stages
    4.2 Global Alzheimer's Treatment Drug Market Size by Application
        4.2.1 Global Alzheimer's Treatment Drug Market Size Overview by Application (2018-2029)
        4.2.2 Global Alzheimer's Treatment Drug Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Alzheimer's Treatment Drug Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Alzheimer's Treatment Drug Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Alzheimer's Treatment Drug Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Alzheimer's Treatment Drug Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Alzheimer's Treatment Drug Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Alzheimer's Treatment Drug Sales Breakdown by Application (2018-2023)

 5 North America Alzheimer's Treatment Drug by Country
    5.1 North America Alzheimer's Treatment Drug Historic Market Size by Country
        5.1.1 North America Alzheimer's Treatment Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Alzheimer's Treatment Drug Sales in Volume by Country (2018-2023)
        5.1.3 North America Alzheimer's Treatment Drug Sales in Value by Country (2018-2023)
    5.2 North America Alzheimer's Treatment Drug Forecasted Market Size by Country
        5.2.1 North America Alzheimer's Treatment Drug Sales in Volume by Country (2024-2029)
        5.2.2 North America Alzheimer's Treatment Drug Sales in Value by Country (2024-2029)

 6 Europe Alzheimer's Treatment Drug by Country
    6.1 Europe Alzheimer's Treatment Drug Historic Market Size by Country
        6.1.1 Europe Alzheimer's Treatment Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Alzheimer's Treatment Drug Sales in Volume by Country (2018-2023)
        6.1.3 Europe Alzheimer's Treatment Drug Sales in Value by Country (2018-2023)
    6.2 Europe Alzheimer's Treatment Drug Forecasted Market Size by Country
        6.2.1 Europe Alzheimer's Treatment Drug Sales in Volume by Country (2024-2029)
        6.2.2 Europe Alzheimer's Treatment Drug Sales in Value by Country (2024-2029)

 7 Asia-Pacific Alzheimer's Treatment Drug by Region
    7.1 Asia-Pacific Alzheimer's Treatment Drug Historic Market Size by Region
        7.1.1 Asia-Pacific Alzheimer's Treatment Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Alzheimer's Treatment Drug Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Alzheimer's Treatment Drug Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Alzheimer's Treatment Drug Forecasted Market Size by Region
        7.2.1 Asia-Pacific Alzheimer's Treatment Drug Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Alzheimer's Treatment Drug Sales in Value by Region (2024-2029)

 8 Latin America Alzheimer's Treatment Drug by Country
    8.1 Latin America Alzheimer's Treatment Drug Historic Market Size by Country
        8.1.1 Latin America Alzheimer's Treatment Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Alzheimer's Treatment Drug Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Alzheimer's Treatment Drug Sales in Value by Country (2018-2023)
    8.2 Latin America Alzheimer's Treatment Drug Forecasted Market Size by Country
        8.2.1 Latin America Alzheimer's Treatment Drug Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Alzheimer's Treatment Drug Sales in Value by Country (2024-2029)

 9 Middle East and Africa Alzheimer's Treatment Drug by Country
    9.1 Middle East and Africa Alzheimer's Treatment Drug Historic Market Size by Country
        9.1.1 Middle East and Africa Alzheimer's Treatment Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Alzheimer's Treatment Drug Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Alzheimer's Treatment Drug Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Alzheimer's Treatment Drug Forecasted Market Size by Country
        9.2.1 Middle East and Africa Alzheimer's Treatment Drug Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Alzheimer's Treatment Drug Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 AbbVie
        10.1.1 AbbVie Company Information
        10.1.2 AbbVie Introduction and Business Overview
        10.1.3 AbbVie Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 AbbVie Alzheimer's Treatment Drug Products Offered
        10.1.5 AbbVie Recent Development
    10.2 Eisai
        10.2.1 Eisai Company Information
        10.2.2 Eisai Introduction and Business Overview
        10.2.3 Eisai Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Eisai Alzheimer's Treatment Drug Products Offered
        10.2.5 Eisai Recent Development
    10.3 Novartis
        10.3.1 Novartis Company Information
        10.3.2 Novartis Introduction and Business Overview
        10.3.3 Novartis Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Novartis Alzheimer's Treatment Drug Products Offered
        10.3.5 Novartis Recent Development
    10.4 Daiichi Sankyo
        10.4.1 Daiichi Sankyo Company Information
        10.4.2 Daiichi Sankyo Introduction and Business Overview
        10.4.3 Daiichi Sankyo Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Daiichi Sankyo Alzheimer's Treatment Drug Products Offered
        10.4.5 Daiichi Sankyo Recent Development
    10.5 Merz Pharma
        10.5.1 Merz Pharma Company Information
        10.5.2 Merz Pharma Introduction and Business Overview
        10.5.3 Merz Pharma Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Merz Pharma Alzheimer's Treatment Drug Products Offered
        10.5.5 Merz Pharma Recent Development
    10.6 Pfizer
        10.6.1 Pfizer Company Information
        10.6.2 Pfizer Introduction and Business Overview
        10.6.3 Pfizer Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 Pfizer Alzheimer's Treatment Drug Products Offered
        10.6.5 Pfizer Recent Development
    10.7 Johnson and Johnson
        10.7.1 Johnson and Johnson Company Information
        10.7.2 Johnson and Johnson Introduction and Business Overview
        10.7.3 Johnson and Johnson Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.7.4 Johnson and Johnson Alzheimer's Treatment Drug Products Offered
        10.7.5 Johnson and Johnson Recent Development
    10.8 Lundbeck
        10.8.1 Lundbeck Company Information
        10.8.2 Lundbeck Introduction and Business Overview
        10.8.3 Lundbeck Alzheimer's Treatment Drug Sales, Revenue and Gross Margin (2018-2023)
        10.8.4 Lundbeck Alzheimer's Treatment Drug Products Offered
        10.8.5 Lundbeck Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Alzheimer's Treatment Drug Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Alzheimer's Treatment Drug Industrial Chain Analysis
    11.4 Alzheimer's Treatment Drug Market Dynamics
        11.4.1 Alzheimer's Treatment Drug Industry Trends
        11.4.2 Alzheimer's Treatment Drug Market Drivers
        11.4.3 Alzheimer's Treatment Drug Market Challenges
        11.4.4 Alzheimer's Treatment Drug Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Alzheimer's Treatment Drug Distributors
    12.3 Alzheimer's Treatment Drug Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

Table of Figures

List of Tables
    Table 1. Major Company of Donepezil
    Table 2. Major Company of Memantine
    Table 3. Major Company of Rivastigmine
    Table 4. Global Alzheimer's Treatment Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 6. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Alzheimer's Treatment Drug Market Share in Value by Type (2018-2023)
    Table 9. Global Alzheimer's Treatment Drug Price by Type (2018-2023) & (US$/Pill)
    Table 10. Global Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 11. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Alzheimer's Treatment Drug Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Alzheimer's Treatment Drug Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Alzheimer's Treatment Drug Price by Type (2024-2029) & (US$/Pill)
    Table 15. North America Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 16. North America Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Alzheimer's Treatment Drug Sales (K Pills) by Type (2018-2023)
    Table 18. Europe Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Alzheimer's Treatment Drug Sales (K Pills) by Type (2018-2023)
    Table 20. Asia-Pacific Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Alzheimer's Treatment Drug Sales (K Pills) by Type (2018-2023)
    Table 22. Latin America Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Alzheimer's Treatment Drug Sales (K Pills) by Type (2018-2023)
    Table 24. Middle East and Africa Alzheimer's Treatment Drug Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Alzheimer's Treatment Drug Sales by Company (2018-2023) & (K Pills)
    Table 26. Global Alzheimer's Treatment Drug Sales Share by Company (2018-2023)
    Table 27. Global Alzheimer's Treatment Drug Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Alzheimer's Treatment Drug Revenue Share by Company (2018-2023)
    Table 29. Global Market Alzheimer's Treatment Drug Price by Company (2018-2023) & (US$/Pill)
    Table 30. Global Alzheimer's Treatment Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Alzheimer's Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drug as of 2022)
    Table 33. Date of Key Manufacturers Enter into Alzheimer's Treatment Drug Market
    Table 34. Key Manufacturers Alzheimer's Treatment Drug Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Alzheimer's Treatment Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Alzheimer's Treatment Drug Sales by Region (2018-2023) & (K Pills)
    Table 38. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Alzheimer's Treatment Drug Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Alzheimer's Treatment Drug Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 42. Global Alzheimer's Treatment Drug Sales by Region (2024-2029) & (K Pills)
    Table 43. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Alzheimer's Treatment Drug Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Alzheimer's Treatment Drug Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2024-2029)
    Table 47. Global Alzheimer's Treatment Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 49. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Alzheimer's Treatment Drug Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Alzheimer's Treatment Drug Price by Application (2018-2023) & (US$/Pill)
    Table 53. Global Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 54. Global Alzheimer's Treatment Drug Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Alzheimer's Treatment Drug Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Alzheimer's Treatment Drug Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Alzheimer's Treatment Drug Price by Application (2024-2029) & (US$/Pill)
    Table 58. North America Alzheimer's Treatment Drug Sales by Application (2018-2023) (K Pills) 
    Table 59. North America Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Alzheimer's Treatment Drug Sales by Application (2018-2023) (K Pills) 
    Table 61. Europe Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Alzheimer's Treatment Drug Sales by Application (2018-2023) (K Pills) 
    Table 63. Asia-Pacific Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Alzheimer's Treatment Drug Sales by Application (2018-2023) (K Pills) 
    Table 65. Latin America Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Alzheimer's Treatment Drug Sales by Application (2018-2023) (K Pills) 
    Table 67. Middle East and Africa Alzheimer's Treatment Drug Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 69. North America Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Alzheimer's Treatment Drug Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Alzheimer's Treatment Drug Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 73. North America Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Alzheimer's Treatment Drug Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Alzheimer's Treatment Drug Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 77. Europe Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Alzheimer's Treatment Drug Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Alzheimer's Treatment Drug Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 81. Europe Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Alzheimer's Treatment Drug Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Alzheimer's Treatment Drug Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Alzheimer's Treatment Drug Sales by Region (2018-2023) & (K Pills)
    Table 85. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Alzheimer's Treatment Drug Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Alzheimer's Treatment Drug Sales by Region (2024-2029) & (K Pills)
    Table 89. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Alzheimer's Treatment Drug Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 93. Latin America Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Alzheimer's Treatment Drug Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Alzheimer's Treatment Drug Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 97. Latin America Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Alzheimer's Treatment Drug Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Alzheimer's Treatment Drug Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 101. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Alzheimer's Treatment Drug Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 105. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Alzheimer's Treatment Drug Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Value by Country (2024-2029)
    Table 108. AbbVie Company Information
    Table 109. AbbVie Introduction and Business Overview
    Table 110. AbbVie Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 111. AbbVie Alzheimer's Treatment Drug Product
    Table 112. AbbVie Recent Development
    Table 113. Eisai Company Information
    Table 114. Eisai Introduction and Business Overview
    Table 115. Eisai Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 116. Eisai Alzheimer's Treatment Drug Product
    Table 117. Eisai Recent Development
    Table 118. Novartis Company Information
    Table 119. Novartis Introduction and Business Overview
    Table 120. Novartis Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 121. Novartis Alzheimer's Treatment Drug Product
    Table 122. Novartis Recent Development
    Table 123. Daiichi Sankyo Company Information
    Table 124. Daiichi Sankyo Introduction and Business Overview
    Table 125. Daiichi Sankyo Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 126. Daiichi Sankyo Alzheimer's Treatment Drug Product
    Table 127. Daiichi Sankyo Recent Development
    Table 128. Merz Pharma Company Information
    Table 129. Merz Pharma Introduction and Business Overview
    Table 130. Merz Pharma Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 131. Merz Pharma Alzheimer's Treatment Drug Product
    Table 132. Merz Pharma Recent Development
    Table 133. Pfizer Company Information
    Table 134. Pfizer Introduction and Business Overview
    Table 135. Pfizer Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 136. Pfizer Alzheimer's Treatment Drug Product
    Table 137. Pfizer Recent Development
    Table 138. Johnson and Johnson Company Information
    Table 139. Johnson and Johnson Introduction and Business Overview
    Table 140. Johnson and Johnson Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 141. Johnson and Johnson Alzheimer's Treatment Drug Product
    Table 142. Johnson and Johnson Recent Development
    Table 143. Lundbeck Company Information
    Table 144. Lundbeck Introduction and Business Overview
    Table 145. Lundbeck Alzheimer's Treatment Drug Sales (K Pills), Revenue (Million USD), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 146. Lundbeck Alzheimer's Treatment Drug Product
    Table 147. Lundbeck Recent Development
    Table 148. Key Raw Materials Lists
    Table 149. Raw Materials Key Suppliers Lists
    Table 150. Alzheimer's Treatment Drug Market Trends
    Table 151. Alzheimer's Treatment Drug Market Drivers
    Table 152. Alzheimer's Treatment Drug Market Challenges
    Table 153. Alzheimer's Treatment Drug Market Restraints
    Table 154. Alzheimer's Treatment Drug Distributors List
    Table 155. Alzheimer's Treatment Drug Downstream Customers
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Treatment Drug Product Picture
    Figure 2. Global Alzheimer's Treatment Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Alzheimer's Treatment Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Alzheimer's Treatment Drug Sales Status and Outlook (2018-2029) & (K Pills)
    Figure 5. Product Picture of Donepezil
    Figure 6. Global Donepezil Sales YoY Growth (2018-2029) & (K Pills)
    Figure 7. Product Picture of Memantine
    Figure 8. Global Memantine Sales YoY Growth (2018-2029) & (K Pills)
    Figure 9. Product Picture of Rivastigmine
    Figure 10. Global Rivastigmine Sales YoY Growth (2018-2029) & (K Pills)
    Figure 11. Global Alzheimer's Treatment Drug Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Alzheimer's Treatment Drug Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Alzheimer's Treatment Drug Sales Market Share in Volume by Type in 2022
    Figure 14. North America Alzheimer's Treatment Drug Sales Market Share in Value by Type in 2022
    Figure 15. Europe Alzheimer's Treatment Drug Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Alzheimer's Treatment Drug Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Alzheimer's Treatment Drug Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Alzheimer's Treatment Drug Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer's Treatment Drug Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer's Treatment Drug Revenue in 2022
    Figure 25. Alzheimer's Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Early to Moderate Stages
    Figure 27. Global Early to Moderate Stages Sales YoY Growth (2018-2029) & (K Pills)
    Figure 28. Product Picture of Moderate to Severe Stages
    Figure 29. Global Moderate to Severe Stages Sales YoY Growth (2018-2029) & (K Pills)
    Figure 30. Global Alzheimer's Treatment Drug Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Alzheimer's Treatment Drug Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Alzheimer's Treatment Drug Sales Market Share in Volume by Application in 2022
    Figure 33. North America Alzheimer's Treatment Drug Sales Market Share in Value by Application in 2022
    Figure 34. Europe Alzheimer's Treatment Drug Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Alzheimer's Treatment Drug Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Alzheimer's Treatment Drug Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Alzheimer's Treatment Drug Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Alzheimer's Treatment Drug Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Alzheimer's Treatment Drug Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Alzheimer's Treatment Drug Manufacturing Cost Structure
    Figure 43. Alzheimer's Treatment Drug Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed

Description

The global Alzheimer's Treatment Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Treatment Drug in various end use industries. The expanding demands from the Early to Moderate Stages and Moderate to Severe Stages, are propelling Alzheimer's Treatment Drug market. Donepezil, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Memantine segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alzheimer's Treatment Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Alzheimer's Treatment Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Alzheimer's Treatment Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alzheimer's Treatment Drug sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Alzheimer's Treatment Drug covered in this report include AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson and Lundbeck, etc.

The global Alzheimer's Treatment Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2023-12-08

Pages: 93 Pages

Report ld: 1946396

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License